Effect of Murivenna Application in Stage 1 Pressure ulcer

A Comparative Clinical Study To Assess The Effectiveness Of Murivenna Versus The Standard Of Care In Stage 1 Pressure Ulcer

Status

Recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/03/018298

Enrollment

Registered

2019-03-28

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L899- Pressure ulcer of unspecified site

Interventions

Intervention1: MURIVENNA: Murivenna is an Ayurvedic medicinal oil, that has to be applied on Stage 1 Pressure ulcer, twice daily for a maximum span of 45 days. Control Intervention1: Mupirocin ointmen

Eligibility

Inclusion criteria

Inclusion criteria: Volunteers with Stage 1 pressure ulcer.

Exclusion criteria

Exclusion criteria: Patients having underlying diseases like Diabetes mellitus, malignancy, HIV infection, jaundice and other immuno compromised conditions are excluded. Persons in the habit of smoking, drug abuse are also excluded from the study.

Design outcomes

Primary

Measure	Time frame
PUSH tools for assessment of healingTimepoint: 60 days	—

Secondary

Measure	Time frame
SF 36 questionnaire and VAS for quality of life assessmentTimepoint: 60 days	—

Countries

India

Contacts

Public ContactDr Rabinarayan Tripathy

drrabi73@gmail.com08129292391

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026